Dr Timothy Lim Yong Kuei is a Specialist in Obstetrics and Gynaecology with a special interest in the management of gynaecological cancers. Though his key interests are in laparoscopic surgery, complex pelvic surgery and the prevention and treatment of gynaecological cancers, he also provides antenatal care to expectant mothers and manages a wide range of gynaecological conditions including endometriosis, fibroids and ovarian cysts.
He graduated from the National University of Singapore in 1998 and obtained his post-graduate qualifications in O&G from the Royal College of O&G, London in 2003. He started his gynaecological oncology fellowship training in the Department of Gynaecological Oncology, KKH under A/Prof Philip Yam in 2006 and was awarded the prestigious Health Manpower Development Programme (HMDP) award from MOH to train in minimally invasive gynaecological cancer surgery in France under the tutelage of the renowned Prof Denis Querleuin 2008. He also obtained the Masters in Law (LLM) in Medical Law and Ethics at the University of Edinburgh in 2016.
He was the Head and Senior Consultant Gynaecologist of the Department of Gynaecological Oncology, KKH from 2014 to 2019 as well as the Deputy Chairman of the Division of O&G, KKH from October 2015 to 2019. He was instrumental in the development of minimally invasive gynae-cancer surgery as a standard of care in KKH as well as starting the ICG-NIR sentinel lymph node biopsy services for endometrial cancers since 2016. He performed the first laparoscopic Wertheim’s radical hysterectomy in Singapore for cervical cancer in 2009, introduced fertility sparing abdominal radical trachelectomyfor early cervical cancer in KKH in 2011 with successful pregnancies after surgery as well as the first ICG-NIR sentinel lymph node biopsy for early endometrial cancer in Singapore in Dec 2015. He also introduced digital colposcopy services in the management of preinvasivediseases in the colposcopy suites, KKH in 2016.
He was also the Academic Vice-Chair of Research in the SinghealthO&G Academic Clinical Program (ACP) from April 2018 to 2019. As a clinical researcher, he has authored and co-authored more than 40 peer reviewed papers. He was also the principal investigator in several multicentre HPV vaccine clinical trials as well as co-investigator in several multicentre chemotherapy trials in KK hospital. He sits in the editorial board of the World Journal of Clinical Cases and Journal of Cancer Metastasis and Treatment (JCMT) and is an associate editor of the Singapore Journal of O&G.